News Government Manufacturing General
October 29, 2020  

Cost for cancer drugs triples in Canada, still no national drug plan

Data shows cancer medications account for about 15% of all spending on pharmaceuticals.

News Government Manufacturing Economy General
October 26, 2020  

Pfizer raises concerns on probe of Ottawa’s pandemic response

Raises confidentiality related to requirement to produce documents related to the production and purchase of a vaccine for COVID-19.

News Government Manufacturing General
July 20, 2020  

UK is buying 90M coronavirus vaccine doses

Has accessed to candidates being developed by a Pfizer, BioNTech, and another experimental vaccine researched by Valneva.

News Manufacturing Business Operations General
July 2, 2020  

Novartis pays $678M to resolve suit over sham doctor outings

Company splurged on speaking fees, exorbitant meals, and top-shelf alcohol to get doctors to prescribe Novartis’s drugs.

News Manufacturing General
April 13, 2020  

Apotex Pharmachem produces hand sanitizer

The Brantford, Ont.-based division of Apotex is producing 1,200 litres of sanitizer in the coming weeks

News Manufacturing General
March 10, 2020  

Bora Pharmaceuticals acquires GSK Mississauga facility

The transaction is expected to be complete by the end of 2020.

News General
September 25, 2018  

Novartis plans to cut 2,100 jobs in Switzerland, Britain

Swiss pharmaceuticals giant hopes to lower its overall headcount worldwide to below 100,000, from about 126,000 today.

News Government Manufacturing Economy General
September 17, 2018  

Freeland to return to NAFTA talks in Washington this week

Intense discussions continue but stalling over dispute settlement mechanism.

News Manufacturing General
June 14, 2016  

Valeant invests $10M in Laval plant upgrades

Enhances manufacturing capabilities and export capacity.

News Manufacturing Business Operations General Operations Production
June 7, 2016  

Valeant invests $8M in Manitoba manufacturing plant

Company to transfer North American production of Xifaxan and Apriso to Steinbach facility.

News Manufacturing General
April 7, 2016  

Lawyer pushing Cold fX class action is ‘manufacturing’ case: Valeant

Pharmaceutical firm’s lawyer cites an absence of an easily defined class of complainants.

News Manufacturing General
April 4, 2016  

Cold-fX case should receive class action approval: lawsuit

Makers accused of misleading the public about remedy’s short-term effectiveness.

News Government Manufacturing General
October 5, 2015  

Overnight suspense over TPP, on verge of completion

Trade deal stalled over next-gen pharmaceuticals that delayed resolution of other issues.

News Government Manufacturing General
August 11, 2015  

Canada Drugs faces US charges for counterfeit drugs

Online pharmacy based in Winnipeg accused of smuggling, money laundering and conspiracy.

News Business Operations Operations Technology
October 31, 2013  

CETA to increase drug costs by up to $1.65B

Analysts says delaying the arrival of cheaper generic drugs will add up to 13%.